John Alexander Kelly Precision Biosciences Inc (DTIL) insider trading activity

DTIL Quotes by TradingView

John Alexander Kelly is Chief Financial Officer of PRECISION BIOSCIENCES INC. Currently has a direct ownership of 40,186 shares of DTIL, which is worth approximately $171,192. The most recent transaction as insider was on Dec 27, 2024, when has been sold 2,113 shares (Common Stock) at a price of $4.75 per share, resulting in proceeds of $10,036. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 40.2K
27.7% 3M change
91.92% 12M change
Total Value Held $171,192

John Alexander Kelly Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 27 2024
BUY
Open market or private purchase
$10,036 $4.75 p/Share
2,113 Added 5.0%
40,186 Common Stock
Nov 21 2024
BUY
Open market or private purchase
$20,280 $6.76 p/Share
3,000 Added 7.3%
38,073 Common Stock
Nov 02 2024
BUY
Exercise of conversion of derivative security
-
3,605 Added 9.32%
35,073 Common Stock
Jun 07 2024
BUY
Exercise of conversion of derivative security
-
454 Added 1.42%
31,468 Common Stock
May 08 2024
BUY
Grant, award, or other acquisition
$100,008 $12.0 p/Share
8,334 Added 21.18%
31,014 Common Stock
May 01 2024
BUY
Exercise of conversion of derivative security
-
1,702 Added 6.98%
22,680 Common Stock
Feb 29 2024
BUY
Grant, award, or other acquisition
$9,361 $18.5 p/Share
506 Added 2.36%
20,978 Common Stock
Jan 20 2024
BUY
Exercise of conversion of derivative security
-
116,690 Added 15.97%
614,169 Common Stock
Nov 02 2023
BUY
Exercise of conversion of derivative security
-
108,188 Added 17.86%
497,479 Common Stock
Aug 31 2023
BUY
Grant, award, or other acquisition
$2,320 $0.39 p/Share
5,951 Added 1.51%
389,291 Common Stock
Aug 18 2023
BUY
Grant, award, or other acquisition
$43,200 $0.48 p/Share
90,000 Added 19.01%
383,340 Common Stock
Jun 07 2023
BUY
Exercise of conversion of derivative security
-
47,726 Added 13.99%
293,340 Common Stock
Mar 17 2023
BUY
Open market or private purchase
$17,200 $0.86 p/Share
20,000 Added 7.53%
245,614 Common Stock
Mar 03 2023
BUY
Exercise of conversion of derivative security
-
51,071 Added 18.46%
225,614 Common Stock
Feb 28 2023
BUY
Grant, award, or other acquisition
$11,024 $0.95 p/Share
11,605 Added 6.23%
174,543 Common Stock
Sep 23 2022
BUY
Open market or private purchase
$10,086 $1.23 p/Share
8,200 Added 4.79%
162,938 Common Stock
Sep 22 2022
BUY
Open market or private purchase
$49,630 $1.34 p/Share
37,037 Added 19.31%
154,738 Common Stock
Jun 22 2022
BUY
Open market or private purchase
$50,676 $1.5 p/Share
33,784 Added 22.3%
117,701 Common Stock
Jun 07 2022
BUY
Exercise of conversion of derivative security
-
47,728 Added 36.26%
83,917 Common Stock
Mar 17 2022
BUY
Open market or private purchase
$51,365 $3.08 p/Share
16,677 Added 31.55%
36,189 Common Stock
Feb 28 2022
BUY
Grant, award, or other acquisition
$9,798 $3.61 p/Share
2,714 Added 12.21%
19,512 Common Stock
Aug 31 2021
BUY
Grant, award, or other acquisition
$10,659 $10.68 p/Share
998 Added 5.61%
16,798 Common Stock
JAK

John Alexander Kelly

Chief Financial Officer
Durham, NC

Track Institutional and Insider Activities on DTIL

Follow PRECISION BIOSCIENCES INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DTIL shares.

Notify only if

Insider Trading

Get notified when an Precision Biosciences Inc insider buys or sells DTIL shares.

Notify only if

News

Receive news related to PRECISION BIOSCIENCES INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DTIL